1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,031 | 0,032 | 15:26 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| Di | Bioretec Oy: New Shares | 139 | GlobeNewswire | EXCHANGE NOTICE, APRIL 07, 2026 SHARES (Record Id 341593)
A maximum of 1,477,828,416 new shares (BRETECN0126) of the share issue of Bioretec Oy will be traded as new shares as of April 08,... ► Artikel lesen | |
| 02.04. | Bioretec Ltd publishes an exemption document relating to its rights issue | 291 | PR Newswire | Bioretec Ltd Company release 2 April 2026 at 3:00 p.m. EESTNOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG... ► Artikel lesen | |
| 02.04. | Bioretec Oy: Bioretec Ltd publishes an exemption document relating to its rights issue | 131 | GlobeNewswire (Europe) | Bioretec Ltd Company release 2 April 2026 at 3:00 p.m. EEST
Bioretec Ltd publishes an exemption document relating to its rights issue
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN... ► Artikel lesen | |
| 02.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 02.04.2026 | 443 | Xetra Newsboard | Das Instrument PW2 US7391281067 POWELL IND. INC. DL -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.04.2026 und ex Kapitalmassnahme am 07.04.2026 The instrument PW2 US7391281067 POWELL IND. INC.... ► Artikel lesen | |
| 27.03. | Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue | 352 | PR Newswire | Bioretec Ltd Inside information 27 March 2026 at 12:50 p.m. EETNOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE... ► Artikel lesen | |
| 27.03. | Bioretec Oy: Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue | 121 | GlobeNewswire (Europe) | Bioretec Ltd Inside information 27 March 2026 at 12:50 p.m. EET
Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes... ► Artikel lesen | |
| 27.03. | Bioretec Ltd's resolutions of the Extraordinary General Meeting | 251 | PR Newswire | Bioretec Ltd Company release 27 March 2026 at 11:05 a.m. EETHELSINKI, Finland, March 27, 2026 /PRNewswire/ -- Bioretec Ltd's resolutions of the Extraordinary General Meeting
Bioretec... ► Artikel lesen | |
| 26.03. | Bioretec: The Finnish Financial Supervisory Authority has granted Stephen Industries Inc Oy and Kustaa Poutiainen a permanent exemption from the obligation to launch a mandatory public takeover bid | 349 | PR Newswire | NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC... ► Artikel lesen | |
| 24.03. | Change to the publication date of Business Review: Bioretec publishes January-March 2026 Business Review on 15 May 2026 | 215 | PR Newswire | Bioretec Ltd Financial calendar 24 March 2026 at 1:45 p.m. EETTAMPERE, Finland, March 24, 2026 /PRNewswire/ -- Bioretec Ltd publishes its January-March 2026 Business Review on 15 May 2026.... ► Artikel lesen | |
| 13.03. | Bioretec Ltd's Financial Statements and Annual Report 2025 published | 365 | PR Newswire | Bioretec Ltd | Company announcement | 13 March 2026 at 5:15 p.m.TAMPERE, Finland, March 13, 2026 /PRNewswire/ -- Bioretec Ltd has today published its 2025 Financial Statements and Annual... ► Artikel lesen | |
| 12.03. | Inside information: Timo Lehtonen takes on a new role at Bioretec as External Executive Advisor and steps down from the management team | 4 | Cision News | ||
| 10.03. | Inside information: Bioretec Ltd is planning a rights issue of at least EUR 5 million and up to EUR 15 million with a maximum of 1,500,000,000 new shares | 464 | PR Newswire | Bioretec Ltd Inside information 10 March 2026 at 21:30 p.m. EETNOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE... ► Artikel lesen | |
| 10.03. | Notice of the Extraordinary General Meeting of Bioretec Ltd | 547 | PR Newswire | Bioretec Ltd | Company announcement | 10 March 2026 at 21:31 p.m. EETHELSINKI, Finland, March 10, 2026 /PRNewswire/ -- NOTICE OF THE EXTRAORDINARY GENERAL MEETING OF BIORETEC LTD
The... ► Artikel lesen | |
| 13.02. | Inside information: Bioretec Ltd's Board of Directors is assessing a potential rights issue in the near future | 548 | PR Newswire | Bioretec Ltd Inside information 13 February 2026 at 9.31 a.m. EETNOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE... ► Artikel lesen | |
| 13.02. | BIORETEC: A year of rebuilding and renewed focus | 4 | Cision News | ||
| 13.02. | Bioretec Oy: A year of rebuilding and renewed focus | 275 | GlobeNewswire (Europe) | Bioretec Ltd Company announcement 13 February 2025 at 9:30 a.m.
This company announcement is a summary of Bioretec Ltd's financial statements bulletin for January-December 2025. The complete financial... ► Artikel lesen | |
| 09.02. | Bioretec Ltd's financial statements bulletin for January-December 2025 will be published on February 13, 2026 | 4 | Cision News | ||
| 30.01. | Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2026 | 387 | PR Newswire | Bioretec Ltd Company announcement 30 January 2026 at 1.45 p.m EETTAMPERE, Finland, Jan. 30, 2026 /PRNewswire/ -- The Shareholders' Nomination Board of Bioretec Ltd ("Bioretec") has resolved... ► Artikel lesen | |
| 16.01. | Bioretec: CMS Transitional Pass-Through Payment (TPT) description for HCPCS code C1741 has been revised | 850 | PR Newswire | TAMPERE, Finland, Jan. 16, 2026 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, was granted Transitional Pass-Through Payment (TPT) status by the U.S. Centers for... ► Artikel lesen | |
| 15.01. | Bioretec beruft Tuukka Paavola zum neuen Finanzvorstand | 13 | Investing.com Deutsch |
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,600 | +1,60 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106 Augenapplikatoren | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106... ► Artikel lesen | |
| DRAEGERWERK | 94,70 | +0,96 % | Draegerwerk AG & Co. KGaA: Online-Präsentation für Investoren als Teil der German Select 7 Conference am 14.04.2026 | Vor diesem Hintergrund veranstaltet mwb research am 14.04.2026 um 14:00 CEST einen Online-Roundtable mit Thomas Fischler (Head of Treasury & Investor Relations). Nach einer Präsentation besteht die... ► Artikel lesen | |
| INTUITIVE SURGICAL | 383,10 | -0,30 % | Future Market Insights: Global Lung Cancer Surgery Market | Rise at 5.9% CAGR | Medtronic, Ethicon, Intuitive Surgical Drive Precision Oncology Advancements | For healthcare providers, surgical centers, and medical device manufacturers, lung cancer surgery remains a cornerstone of oncology care-particularly for early-stage diagnosis-where precision, patient... ► Artikel lesen | |
| INSULET | 169,35 | +0,83 % | Insulet's Omnipod takes Type 2 diabetes representation to the TV screen in 'Scrubs' revival | ||
| CYTOSORBENTS | 0,545 | +3,81 % | Cytosorbents Corp: CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights | 2025 revenue of $37.1 million, up 4% year-over-year, and 71% Full-year gross margins
Enhanced Balance Sheet Flexibility with an Additional $2.5 million Proceeds... ► Artikel lesen | |
| GENEDX | 59,65 | 0,00 % | Cathie Wood's ARK sells BWX Technologies stock, buys GeneDx | ||
| REVENIO GROUP | 18,380 | -6,22 % | Revenio Group Corporation: Inside information: Revenio accelerates growth and value creation by acquiring Visionix, becoming a leading turnkey solutions provider in the global eye care market | Revenio Group Corporation | Inside Information | April 13, 2026 at 09:30:00 EEST
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA... ► Artikel lesen | |
| OPTOMED | 2,285 | 0,00 % | OPTOMED OYJ: Notice Of The Annual General Meeting Of Optomed Plc | ||
| SIEMENS HEALTHINEERS | 37,430 | +0,24 % | ANALYSE-FLASH: Goldman senkt Ziel für Siemens Healthineers - 'Neutral' | NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 52 auf 45 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Vor der Berichtssaison... ► Artikel lesen | |
| FRESENIUS | 44,200 | -0,67 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| PROGYNY | 16,300 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BILLIONTOONE | 81,13 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,080 | +0,10 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,510 | 0,00 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| BRIGHTSPRING HEALTH SERVICES | 45,330 | 0,00 % | BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026 |
Das Unternehmen BIORETEC OY kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,003 (-10,24 %) liegt der Kurs bei 0,030 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.